COMPARATIVE ANALYSIS OF CLINICAL MANIFESTATIONS OF ANXIETY AND DEPRESSION IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPY WITH CONCOMITANT TYPE 2 DIABETES MELLITUS

Authors:

Abstract:

This article presents the comparative analysis results on clinical manifestations of anxiety and depression in patients undergoing renal replacement therapy, namely programmed hemodialysis, taking into account the concomitant type 2 diabetes mellitus. Patients undergoing renal replacement therapy, namely, program hemodialysis, have a higher risk of anxiety and depressive disorders than patients with chronic stage I-II kidney disease undergoing conservative therapy. Concomitant diabetes mellitus in patients undergoing renal replacement therapy causes an increase in the frequency of anxiety and depression.

Keywords:

chronic kidney disease diabetes mellitus program hemodialysis anxiety depression

References:

1. Katerenchuk IP, Yarmola TI. Khronichna khvoroba nyrok. Poltava. Navchalnyi posibnyk. 2012: 13–18. [in Ukrainian]
2. Alqarni AM, Alghamdi EA, Alaqil NA, Alzahrani AH, Aldhfyan YM. Prevalence of anxiety and depression and itsrelated influencing factors among patients with end-stage. International Journal of Medical Research&Health Sciences. 2019; 8(1):55–62.
3. Eugene PR, Eliseo G, Seungyoung H, Noori K, Marcello T. Prevalence and Persistence of Uremic Symptoms in Incident Dialysis Patients. Kidney360 2020 Feb; 1(2):86–92. DOI 10.34067/kid.0000072019.
4. Finkelstein FO, Wuerth D, Finkelstein SH. An approach to addressing depression in patients with chronic kidney disease. Blood Purif.2010; 29:121–4. DOI: 10.1159/000245637
5. Goh ZS, Griva K. Anxiety and depression in patients with end-stage renal disease: impact and management challenges - a narrative review. Int J Nephrol Renovasc Dis. 2018; 11:93–102. DOI: 10.2147/IJNRD.S126615
6. Mirzaei M, Ardekani SMY, Mirzaei M, Dehghani A. Prevalence of depression, anxiety and stress among adult population: results of YAZD health study. Iran J Psychiatry. 2019 Apr; 14(2): 137–46.
7. Namkee GC, John ES, Diana MD, Mark EK. Health Care Utilization Among Adults With CKD and Psychological Distress. Kidney Med. 2019 Jul 13;1(4):162–170. DOI: 10.1016/j.xkme.2019.07.002.
8. Nishank J, Fei W, Monica K, Anuoluwapo A, Jerry W. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial. BMC Nephrol. 2019 Oct 29; 20(1):395. DOI: 10.1186/s12882-019-1576-7.
9. Palmer S, Vecchio M, Craig JC. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int.2013; 84(1):179–191. DOI: 10.1038/ki.2013.77
10. Preljevic VT, Osthus TB, Sandvik L. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. Gen Hosp Psychiatry. 2011; 33(5):454–461. DOI: 10.1016/j.genhosppsych.2011.06.010
11. Raymond KH, Neil RP. Recent trends in the prevalence of chronic kidney disease: not the same old song. Curr Opin Nephrol Hypertens. 2017 May; 26(3):187–196. DOI: 10.1097/MNH.0000000000000315.
12. Shervin A. Chronic Kidney Disease, Anxiety and Depression among American Blacks; Does Ethnicity Matter? Int J Travel Med Glob Health. Fall 2014; 2(4):133–139.
13. Um EK. Gender role in anxiety, depression and quality of life in chronic kidney disease patients. Pak J Med Sci. Jan-Feb 2020; 36(2):251–254. DOI: 10.12669/pjms.36.2.869.
14. World Health Organization. Diabetes [Internet]. Available at: https://www. who.int/ health-topics/diabetes#tab=tab_1
15. Zhong SG, Konstadina G. Anxiety and depression in patients with end-stage renal disease: impact and management challenges - a narrative review. Int J Nephrol Renovasc Dis. 2018 Mar 12; 11:93–102. DOI: 10.2147/IJNRD.S126615.

Publication:

«World of Medicine and Biology» Vol. 17 No. 75 (2021) , с. 144-148
УДК 616.61-036.86:616.8-085.851

DOI:

https://doi.org/10.26724/2079-8334-2021-1-75-144-148